SGLT2 inhibitors represent one of the most remarkable therapeutic developments in heart failure care, transitioning from ...
Sodium-glucose cotransporter-2 (SGLT-2) inhibitors are associated with a reduced risk for autoimmune rheumatic diseases.
News Medical on MSN
Stem cell therapy linked to lower risk of heart failure after a heart attack
Patients with weak heart function who receive stem cell therapy shortly after a heart attack are at lower risk of developing heart failure and related hospital stays compared with standard care, finds ...
Angiotensin receptor-neprilysin inhibitors (ARNIs) represent a significant advancement in heart failure therapy, combining an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback